Search

RESEARCH

University College London | Professor Nish Chaturvedi

Patients with diabetes have a higher chance of later having heart failure, dementia, heart attacks, or strokes compared with people who don’t have diabetes. The exact reasons for this are unknown. With an ageing population, diabetes is beco...

New research in Leicester, which we funded, could help understand how heart failure can develop in people living with Type 2 diabetes.

We were honoured to be one of the chosen beneficiaries of the fifth annual Arora Ball alongside Diabetes UK and Thames Hospice.

The UK's largest retailer, Tesco, has partnered with us, Cancer Research UK and Diabetes UK to help tackle some of the UK's biggest health challenges.

Fats have important regulatory roles that help the heart to conserve energy when blood supply to the heart muscle is reduced, such as in a heart attack. Researchers from the University of Oxford think that the increased levels of fats seen in the hearts of people with type 2 diabetes might make their cells resistant to these important effects. They found that the hearts of rats with type 2 diabetes use up their energy supplies more quickly than those without the condition during a heart attack. This leaves their hearts with less energy – a strong predictor of worse outcomes after heart attack.

The BHF supported the ASCEND trial, to find out whether a daily aspirin tablet and/or a fish oil capsule could help to prevent these conditions in people with diabetes.

Research we've funded at the University of Oxford has identified a drug, currently in clinical trials for another condition, that could reduce the risk that people with diabetes will go on to develop heart failure after a heart attack.

We’ve been funding research to understand better how your ethnic background affects your risk of heart and circulatory diseases and diabetes.

A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs, according to new research that we've funded.

The BHF co-funded the AdDIT trial, which tested whether young people with type 1 diabetes should take medication to lower blood pressure and cholesterol during adolescence to reduce their risk of heart and circulatory diseases.